Meeting highlights from the Committee for Medicinal Products for Human Use,10-13 December 2007 14 December 2007 Press releaseHuman
European Medicines Agency recommends withdrawal of the marketing authorisations for lumiracoxib-containing medicinesReference Number: EMEA/CHMP/579301/2007 English (EN) (29.92 KB - PDF)First published: 13/12/2007 Last updated: 13/12/2007 View Related information Questions and answers on the recommendation to withdraw the marketing authorisations for lumiracoxib-containing medicinesReference Number: EMEA/536363/2007 English (EN) (34.42 KB - PDF)First published: 13/12/2007 Last updated: 13/12/2007 View Questions and answers on recommendation for the refusal of the marketing authorisation for RhucinReference Number: EMEA/567761/2007 English (EN) (35.01 KB - PDF)First published: 13/12/2007 Last updated: 13/12/2007 View Questions and answers on the recommendation to withdraw the marketing authorisations for lumiracoxib-containing medicinesReference Number: EMEA/536363/2007 English (EN) (34.42 KB - PDF)First published: 13/12/2007 Last updated: 13/12/2007 View Contact point Martin Harvey Allchurch or Monika BenstetterTel. (44-20) 74 18 84 27E-mail press@emea.europa.eu Share this page